A Randomized Controlled Trial of the Use of Oral Glucose with or without Gentle Facilitated Tucking of Infants during Neonatal Echocardiography

PLoS One. 2015 Oct 23;10(10):e0141015. doi: 10.1371/journal.pone.0141015. eCollection 2015.

Abstract

Objective: To compare the effect of oral glucose given with or without facilitated tucking (FT), versus placebo (water) to facilitate image acquisition during a targeted neonatal echocardiography (TNE).

Design: Factorial, double blind, randomized controlled trial.

Setting: Tertiary neonatal intensive care unit (NICU).

Patients: Infants born between 26 and 42 weeks of gestation (GA).

Interventions: One of four treatment groups: oral water (placebo), oral glucose (25%), facilitated tucking with oral water or facilitated tucking with oral glucose, during a single, structured TNE. All infants received a soother.

Main outcome measure: Change in Behavioral Indicators of Infant Pain (BIIP) scores.

Results: 104 preterm infants were randomized (mean ± SD GA: 33.4 ± 3.5 weeks). BIIP scores remained low during the echocardiography scan (median, [IQ range]: 0, [0 to 1]). There were no differences in the level of agitation of infants amongst the treatment groups, with estimated reductions in mean BIIP relative to control of 0.27 (95%CI -0.40 to 0.94) with use of oral glucose and .04 (-0.63 to 0.70) with facilitated tucking. There were also no differences between treatment groups in the quality and duration of the echocardiography scans.

Conclusions: In stable infants in the NICU, a TNE can be performed with minimal disruption in a majority of cases, simply by providing a soother. The use of 25% glucose water in this context did not provide further benefit in reducing agitation and improving image acquisition.

Clinical trial registration: Clinical Trials.gov: NCT01253889.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Double-Blind Method
  • Echocardiography / nursing
  • Echocardiography / psychology*
  • Female
  • Glucose / therapeutic use*
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature / psychology
  • Intensive Care Units, Neonatal
  • Intensive Care, Neonatal
  • Male
  • Pain / physiopathology
  • Pain / prevention & control*
  • Pain Measurement
  • Psychomotor Agitation / physiopathology
  • Psychomotor Agitation / prevention & control*

Substances

  • Glucose

Associated data

  • ClinicalTrials.gov/NCT01253889